trending Market Intelligence /marketintelligence/en/news-insights/trending/5st_z0pnpyvpsmli6iqgeq2 content esgSubNav
In This List

Dynavax board member to step down

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Dynavax board member to step down

Dynavax Technologies Corp. said Stanley Plotkin plans to step down as a board member, effective May 31 at the company's annual meeting.

Plotkin, who has been on the immunotherapy company's board since 2005, will continue as scientific adviser for Dynavax.

Berkeley, Calif.-based Dynavax develops therapies for cancers, asthma and hepatitis.